| Literature DB >> 30138943 |
Daiana Stolz1, Jürg Barandun2, Heinz Borer3, Pierre-Olivier Bridevaux4, Patrick Brun5, Martin Brutsche6, Christian Clarenbach7, Christine Eich8, René Fiechter9, Martin Frey10, Thomas Geiser11, Michael Grob12, Erich Helfenstein13, Lilian Junker14, Malcolm Kohler7, Tsogyal Latshang15, Armin Lechmann16, Marc Maurer17, Laurent Nicod18, Franco Quadri19, Daniel Schilter20, Thomas Sigrist10, Paola Soccal21, Philip Tarr22, Robert Thurnheer23, Alexander Turk24, Michael Tamm1.
Abstract
The Swiss National Guidelines 2013 for chronic obstructive pulmonary disease have been revised in order to acknowledge recent progress in diagnosis and management of this disease. The resulting new Swiss recommendations are based on best evidence from the literature, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2018 report and other published national guidelines. Misdiagnosis of chronic obstructive pulmonary disease is common and means that patients do not always receive optimal treatment. To improve the management of patients with chronic obstructive pulmonary disease in Switzerland, these recommendations encourage a more comprehensive assessment of patients, based on the combined assessment of symptoms, degree of airflow limitation, risk of exacerbation and the presence of comorbidities. Recommendations for evidence-based preventive measures, as well as pharmacological and non-pharmacological strategies for the management of both stable and acute exacerbations of chronic obstructive pulmonary disease are provided in this update.Entities:
Keywords: Chronic obstructive pulmonary disease; Exacerbations; Recommendations; Swiss; Treatment; Update
Mesh:
Substances:
Year: 2018 PMID: 30138943 DOI: 10.1159/000490551
Source DB: PubMed Journal: Respiration ISSN: 0025-7931 Impact factor: 3.580